GDC-0941 is a potent inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ with IC50 of 3 nM, 33 nM, 3 nM and 75 nM, respectively. Administration of GDC-0941 in animals displays significant inhibitory effect against established human cancer xenografts. It is currently in clinical trials.
PI3K inhibitors have been used for differentiation of pluripotent stem cells
Purity: Greater than 99% as determined by LC/MS analysis. LC/MS and/or NMR data available upon request.